Not Tagged
Not Tagged
['sclc', 'nsclc', 'biomarker']
safety update includes details on venous thromboembolism with ami/lazer in #egfr nsclc. rr 30% with mdor 10.8m. #met ihc identified as promising biomarker here, seen in 36%. in met high, rr 61% (vs 14%) and mpfs 12.2m (vs 4.2m). #asco23 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo